At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Cutimed Sorbact Hydroactive B wound dressing +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wound Dressings for Hidradenitis Suppurativa
In Brief
A clinical study evaluating Cutimed Sorbact Hydroactive B wound dressing, Cutimed Siltect wound dressing, and 1 other intervention for Hidradenitis Suppurativa. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHidradenitis Suppurativa
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartJan 2020
Primary CompletionMar 2021
TodayJul 2026
First PostedDec 11, 2019
Enrollment StartJan 28, 2020
Primary CompletionMar 8, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.6 years ago
Interventions
Cutimed Sorbact Hydroactive B wound dressingdevice
Wound dressing applied and changed as needed.
Cutimed Siltect wound dressingdevice
Wound dressing applied and changed as needed.
Sorbion Sana multi-star wound dressingdevice
Wound dressing applied and changed as needed.